Trial Profile
Phase II dose-ranging trial of the early bactericidal activity of PA 824
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 May 2012
Price :
$35
*
At a glance
- Drugs Pretomanid (Primary) ; Rifampicin/isoniazid/pyrazinamide/ethambutol
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 28 May 2012 New trial record